Literature DB >> 22517424

Revisiting the role of the granuloma in tuberculosis.

Lalita Ramakrishnan1.   

Abstract

The granuloma, which is a compact aggregate of immune cells, is the hallmark structure of tuberculosis. It is historically regarded as a host-protective structure that 'walls off' the infecting mycobacteria. This Review discusses surprising new discoveries--from imaging studies coupled with genetic manipulations--that implicate the innate immune mechanisms of the tuberculous granuloma in the expansion and dissemination of infection. It also covers why the granuloma can fail to eradicate infection even after adaptive immunity develops. An understanding of the mechanisms and impact of tuberculous granuloma formation can guide the development of therapies to modulate granuloma formation. Such therapies might be effective for tuberculosis as well as for other granulomatous diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22517424     DOI: 10.1038/nri3211

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  155 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis.

Authors:  Bernadette M Saunders; Anthony A Frank; Ian M Orme; Andrea M Cooper
Journal:  Cell Immunol       Date:  2002 Mar-Apr       Impact factor: 4.868

Review 3.  Macrophage turnover, division and activation within developing, peak and "healed" tuberculous lesions produced in rabbits by BCG.

Authors:  Arthur M Dannenberg
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

Review 4.  New insights into the function of granulomas in human tuberculosis.

Authors:  Timo Ulrichs; Stefan H E Kaufmann
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

5.  Relative importance of STAT4 in murine tuberculosis.

Authors:  I Sugawara; H Yamada; S Mizuno
Journal:  J Med Microbiol       Date:  2003-01       Impact factor: 2.472

6.  Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages.

Authors:  P Pancholi; A Mirza; N Bhardwaj; R M Steinman
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

7.  Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.

Authors:  Eugene Trogan; Jonathan E Feig; Snjezana Dogan; George H Rothblat; Véronique Angeli; Frank Tacke; Gwendalyn J Randolph; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-01       Impact factor: 11.205

8.  Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.

Authors:  Andrea Cruz; Alexandra G Fraga; Jeffrey J Fountain; Javier Rangel-Moreno; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Troy D Randall; Jorge Pedrosa; Andrea M Cooper; António G Castro
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

9.  Who benefits from granulomas, mycobacteria or host?

Authors:  Tyler D Bold; Joel D Ernst
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

10.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin.

Authors:  A Molloy; P Laochumroonvorapong; G Kaplan
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  310 in total

Review 1.  Comparative genomics of mycobacteria: some answers, yet more new questions.

Authors:  Marcel A Behr
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

2.  Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection.

Authors:  Nelson C Di Paolo; Shahin Shafiani; Tracey Day; Thalia Papayannopoulou; Thalia Papayannoupoulou; David W Russell; Yoichiro Iwakura; David Sherman; Kevin Urdahl; Dmitry M Shayakhmetov
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

Review 3.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

4.  Latency: A sleeping giant.

Authors:  Courtney Humphries
Journal:  Nature       Date:  2013-10-10       Impact factor: 49.962

5.  Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections.

Authors:  Ranu Surolia; Suman Karki; Zheng Wang; Tejaswini Kulkarni; Fu Jun Li; Shikhar Vohra; Hitesh Batra; Jerry A Nick; Steven R Duncan; Victor J Thannickal; Adrie J C Steyn; Anupam Agarwal; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

6.  Magnetic resonance perfusion and diffusion characteristics of granulomatous diseases mimic those of malignant lesions: six case reports.

Authors:  Misa Sumi; Yukinori Takagi; Miho Sasaki; Sato Eida; Ikuo Katayama; Yuka Hotokezaka; Takashi Nakamura
Journal:  Oral Radiol       Date:  2017-03-16       Impact factor: 1.852

7.  Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.

Authors:  Li-Rung Huang; Dirk Wohlleber; Florian Reisinger; Craig N Jenne; Ru-Lin Cheng; Zeinab Abdullah; Frank A Schildberg; Margarete Odenthal; Hans-Peter Dienes; Nico van Rooijen; Edgar Schmitt; Natalio Garbi; Michael Croft; Christian Kurts; Paul Kubes; Ulrike Protzer; Mathias Heikenwalder; Percy A Knolle
Journal:  Nat Immunol       Date:  2013-04-14       Impact factor: 25.606

8.  TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species.

Authors:  Francisco J Roca; Lalita Ramakrishnan
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 9.  The present state of the tuberculosis drug development pipeline.

Authors:  M Daben J Libardo; Helena Im Boshoff; Clifton E Barry
Journal:  Curr Opin Pharmacol       Date:  2018-08-23       Impact factor: 5.547

Review 10.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.